News by subject: HEALTH

Diabetes Canada is proud to announce the winners of our End Diabetes Awards research competition. Each of the winning research projects has the potential to unlock new insights and breakthroughs in the field of diabetes management, care, and...

Medunik Canada Inc. ("Medunik"), a company dedicated to improving the health and quality of life of Canadians with rare diseases by bringing orphan drugs to Canada, is pleased to announce that on January 9, 2023, the Federal Court of Appeal of Canada...

The Ford government's plans to privatize our public hospitals' vital services are a fatal threat to the core tenet of Canadian Public Medicare that extra user fees are forbidden and patients will not be faced with user charges in their time of need....

VitalHub Corp. (the "Company" or "VitalHub") is pleased to announce a licensing agreement of VitalHub subsidiary Intouch with Health's ("Intouch") Patient Journey Platform by East Sussex Healthcare NHS Trust ("East Sussex" or the "Trust"). East...

CognivAiD provides a long-awaited option to fulfil the unmet needs of patients with vascular dementia. CognivAiD demonstrated significant and clinically meaningful disease-modifying benefits in clinical trials based on VaDAS-Cog and ADCS-CGIC...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announces it will submit an updated briefing package to the U.S....

The Sabin Vaccine Institute today announced that the Biomedical Advanced Research and Development Authority (BARDA) has awarded Sabin a multi-year contract with funding potential for up to $214 million to advance the development and production of...

TJP Labs Inc. ("TJP Labs") is proud to announce the acceptance of its Premarket Tobacco Product Application (PMTA) submission by the U.S. Food and Drug Administration for its brand, L!X modern oral nicotine pouches.  Marketed by its subsidiary L!X...

Field Trip Health & Wellness Ltd. ("Field Trip" or the "Company"), a global leader in the delivery of psychedelic therapies, today launched Field Trip Online Therapy, a unique approach to psychotherapy that leverages contemporary talk therapy,...

Capsa Healthcare, a leading innovator in healthcare delivery solutions for hospitals, long-term care, and retail pharmacy providers, announced the acquisition of Tryten Technologies Inc., a designer and manufacturer of lightweight, easy to maneuver...

Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and...

Algernon Pharmaceuticals Inc. (the "Company" or "AGN Pharma") , a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has appointed Dr. Peter Dicpinigaitis MD, Professor of Medicine at the Albert Einstein...

Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the addition of Neurology Center of New England, P.C. ("NCNE") to its...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announces an independent published study, titled "Omicron Spike...

Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health, is pleased to announce that in a preclinical trial run by the Dr. George Lui lab at the University of California San Diego (UCSD) School of Medicine,...

World Education Services (WES) and Internationally Trained Physicians of Ontario (ITPO) today announced the release of a policy paper calling for implementation of three measures to ensure that internationally trained physicians in Ontario can put...

Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today outlined recent progress in its clinical programs and key milestones for 2023. Mr. Ian...

Clinical-stage pharmaceutical company ENA Respiratory has been awarded a $4.38 million USD agreement from the U.S. Department of Defense (DoD) to support ongoing research and development of INNA-051, a clinical stage first-in-class broad-spectrum...

Algernon Pharmaceuticals Inc. (the "Company" or "AGN Pharma") , a Canadian clinical stage pharmaceutical development company, is pleased to announce that it is planning a 180 patient, 90-day Phase 2b clinical study of NP-120 ("Ifenprodil") for...

Novan, Inc. ("the Company" or "Novan") ,...

Acasti Pharma Inc. ("Acasti" or the "Company") , a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, today announced that it will host a conference call on Tuesday, January 10,...

Curative Biotechnology Inc. ("Curative Biotech" or the "Company"), a development-stage biomedical company focused on novel treatments for rare diseases and conditions, announced today that it has successfully completed its Investigational New Drug...

Helius Medical Technologies today announced the extension of a program that puts the company's Portable Neuromodulation Stimulator (PoNS®) into the hands of qualified Americans with multiple sclerosis (MS) at a significantly reduced cost. This...

Pet Partners, the leading therapy animal registry program in the United States, is proud to announce the national search for its 2023 Pet of the Year. The event is a six-week fundraising competition that will take place February 1 through March 15....

Two women scientists were announced King Faisal Prize for Medicine and Science laureates for 2023: a Covid-19 vaccine developer and a nanotechnology scientist. Six others were announced King Faisal Prize laureates for having enriched humanity with...

With issues like inflation, supply chain disruptions, technological advancements and changing consumer desires, the food system is experiencing a dizzying level of change and unpredictability. But despite that instability?or because of it?several...

Biogen Inc. and Alcyone Therapeutics (Alcyone) have entered into a license and collaboration agreement to develop Alcyone's ThecaFlex DRxtm System, an implantable medical device intended for subcutaneous delivery of antisense oligonucleotide (ASO)...

Reunion Neuroscience Inc. ("Reunion" or "the Company"), a...

Evaxion Biotech A/S ("Evaxion" or the "Company"), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, today announced that the U.S. Food and Drug Administration ("FDA") determined that the Company may...

Samsung Bioepis Co., Ltd. today announced that Health Canada has approved HADLIMAtm (also known as SB5) - a citrate-free, high concentration (40 mg/0.4 ML) formulation of...

Minovia Therapeutics, a clinical-stage global biotechnology company, today announced that the Company will be presenting at the Biotech Showcase on Tuesday, January 10, 2023, at the Hilton San Francisco Union Square Hotel in San Francisco, CA. Time:...

Imagine ringing in the New Year more than 100 times in your lifetime. That is the reality for many Revera retirement home residents, and we can't help but marvel at their extraordinary human achievement - that of a long life well lived. To ring in...

Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180) and...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced that it has submitted the Type C meeting request...

Acasti Pharma Inc. ("Acasti" or the "Company") , a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, today announced that preliminary topline results for its single-dose,...

Ontario joins British Columbia, Alberta, Quebec, New Brunswick, Nova Scotia, Saskatchewan, and the Northwest Territories in implementing a "switch" policy that changes coverage for specific biologic medicines.Biosimilar switch policies are an...

Small Pharma Inc. (the "Company" or "Small Pharma"), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that the last patient has completed its...

Quipt Home Medical Corp. (the "Company") , a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fourth quarter and fiscal year 2022 financial results and operational highlights. These results...

Curium, the world's leading nuclear medicine company, announced today that with the successful restarting of the BR2 research reactor in Belgium on 20 December, Curium's supply of molybdenum-99 (Mo-99) and iodine-131 is continuing as usual. This...

December 21, 2022 Amsterdam, the Netherlands ? Royal Philips today provides an update on the comprehensive test and research program of its subsidiary Philips Respironics, following the voluntary recall notification/field safety notice*...

As 2022 comes to an end, Protein Industries Canada is celebrating the advancement of Canada's plant-based food and ingredient sector, and the achievement of significant milestones as an organization. "Over the past four years, Protein Industries...

Datacubed Health ("Datacubed"), a digital health technology company that supports hybrid and decentralized clinical trials, and Sterling Partners ("Sterling"), a prominent investment management firm, announced December 20, 2022, substantial...

Biogen Inc. announced that it has reached an agreement with Genentech, a member of the Roche Group, related to the commercialization and sharing of economics for glofitamab. Under the terms of the agreement, Biogen will have no payment obligations...

XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the completion of dosing in the XRX-OXY-101...

Wesana Health Holdings Inc. ("Wesana" or the "Company") , a data-driven life sciences company, today announced that Wesana Health Inc. ("WHI"), a subsidiary of the Company, has received an unsecured short-term loan in an aggregate principal amount of...

As Canada's premiers and the federal NDP ramp up the pressure on the Trudeau government, Health Coalitions across Canada are demanding that any increase in public health funding be used in the public interest and not be used to privatize health care....

This holiday season, California Prunes is presenting recipes from Quebec-based chef, Christopher Kassab, who has showcased the many ways to elevate your entertaining with the flavorful, under-the-radar superfood. While many are aware of the health...

Providence Therapeutics Holdings Inc. ("Providence"), a clinical-stage biotechnology company pioneering mRNA vaccines for infectious diseases and oncology, today announced that its new mRNA vaccine program for rabies post-exposure prophylaxis has...

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") , a leader in specialty ketamine pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for ketamine in the prevention of...

BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has signed an exclusive Distribution Agreement with a European partner for a product that is used in oncology supportive...